Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Breast Neoplasms 2Triple Negative Breast Neoplasms 1Toxemia 1Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neoplasms 1Myocarditis 1Muscle Weakness 1Melanoma 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 47enzalutamide 46apalutamide 36Specimen Handling 30Androgen Antagonists 30Abiraterone Acetate 29Radiosurgery 26Prednisone 25darolutamide 24Docetaxel 23Pluvicto 21abiraterone 19Radiotherapy 19Biopsy 17Leuprolide 15Surveys and Questionnaires 11Radiation 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 11relugolix 10gallium 68 PSMA-11 10acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10Standard of Care 10Nivolumab 10cabazitaxel 9Triptorelin Pamoate 9bicalutamide 8Carboplatin 8pembrolizumab 7olaparib 7niraparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Positron-Emission Tomography × 90 days × Clear all
NCT05470699 2026-06-02

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

City of Hope Medical Center

Phase NA Active not recruiting
34 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT05477823 2026-06-02

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

University of Wisconsin, Madison

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06862856 2026-05-15

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Massachusetts General Hospital

Recruiting
50 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05133440 2026-04-28

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
12 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡